期刊文献+

脊柱关节炎的关节外表现及其治疗 被引量:1

下载PDF
导出
摘要 脊柱关节炎(SpA)是一组相互关联的以侵犯脊柱、外周关节和关节周围结构为主的多系统慢性炎症性疾病,包括强直性脊柱炎(AS)、反应性关节炎(ReA)、银屑病关节炎(PsA)、炎性肠病性关节炎、未分化脊柱关节病和幼年发病的脊柱关节病,整体人群患病率为0.5%~1.9%。
作者 张燕平
出处 《山西医药杂志(上半月)》 CAS 2013年第10期1124-1127,共4页 Shanxi Medical Journal
  • 相关文献

参考文献15

  • 1Sieper J, Rudwaleit M, Khan MA, et al. Concepts and epi- demiology of spondyloarthritis. Best Pract Res Clin Rheuma- tol,2006,20:401-417.
  • 2Van der Cruyssen B, Ribbens C, Boonen A, et al. The epide- miology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis, 2007,66 : 1072-1077.
  • 3杨培增,王红,张震,钟华红,俞琼,傅涛,周红颜,黄祥坤.强直性脊椎炎伴发葡萄膜炎的临床特征和治疗[J].中华眼科杂志,2005,41(6):515-518. 被引量:23
  • 4刘雅妮,张莉芸,牛红青,陈小云,谢宝明.强直性脊柱炎伴发急性前色素膜炎临床特点分析[J].山西医药杂志(上半月),2008,37(5):450-451. 被引量:4
  • 5刘湘源,肖玉兰,李胜光,黄烽.B27相关性葡萄膜炎[J].中华风湿病学杂志,2006,10(4):244-247. 被引量:7
  • 6强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(8):557-559. 被引量:866
  • 7Guignard S, Gossec L, Salliot C, et al. Efficacy of turnout necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis, 2006,65 : 1631-1634.
  • 8Brunner F, Kunz A, Weber U, et al. Ankylosing spondylitis and heart abnomalities:do cardiac conduction disorders,valve regurgitation and diastolic dysfunction occur more often in male patients with. diagnosed ankylosing spondyiitis for over 15 years than in the nomal population. Clin Rheumatol, 2006,25:24-29.
  • 9Bergfeldt L. HLA-B27 Assiociated cardiac disease. Ann Int Med,1997,127:621-629.
  • 10程秀峰,谭魁麟,金琰,谭军.活动期强直性脊柱炎心脏受累表现[J].临床内科杂志,2003,20(6):317-318. 被引量:3

二级参考文献79

  • 1贺发贵,汪卫华,马路,周柱亮.强直性脊柱炎继发IgA肾病报告1例[J].中国中西医结合肾病杂志,2006,7(2):118-118. 被引量:5
  • 2刘湘源,肖玉兰,李胜光,黄烽.B27相关性葡萄膜炎[J].中华风湿病学杂志,2006,10(4):244-247. 被引量:7
  • 3[1]Zink A,Braun J,Listing J,et al.Disability and handicap in rheurnatoid arthritis and ankylosing spondylitis-results from the German rheumatological database.J Rheumatol,2000,27:613-622.
  • 4[2]Van der Linden S,Valkcnburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria.Arthritis Rheurn,1984,27:361-368.
  • 5[4]Jaakkola E,Herzberg I,Laiho K,et al.Finish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.Ann Rheum,2006,65:775-780.
  • 6[5]Robertson LP,Davis MJ.A longitudinal study of disease activity and functional Status in a hospital cohort of patients with ankylosing spoudylitis.Rheumatology(Oxford),2004,43:1565-1568.
  • 7[6]Koh WH,Boey ML.Ankylosing spondylitis in Singapore:a study of 150 patients and a local update.Ann Acad Med Singapore,1998,27:3-6.
  • 8[7]Chen CH,Lin KC,Chen HA,et al.Association of acute anterior uveitis with disease activity.functional ability and physical mobility in patiants with ankylosing spondylitis:a cross-sectional study of Chinese patients in Taiwan.Clin Rheumatol,2007,26:953-957.
  • 9[9]Braun J,Barsliakos X,Listing J,et al.Decrease incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor mecrosis factor agents infliximab and etanercept.Arthritis Rheum,2005,52:2447-2451.
  • 10[10]Ward MM,Weisman MH,Davis JC Jr,et al.Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.Arthritis Rheurn,2005,53:710-717.

共引文献905

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部